U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
156091156091Eastbourne Syncope Assessment Study IIRecruitingNo Results AvailableSyncopeDevice: Sleuth Implantable Loop Recorder|Other: Otherhttps://ClinicalTrials.gov/show/NCT00517023
156092156092Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-related Macular DegenerationCompletedNo Results AvailableAge-Related Macular DegenerationOther: Proton beam irradiation and ranibizumabhttps://ClinicalTrials.gov/show/NCT00517010
156093156093Increase Infusion Rates of Intravenous Fat EmulsionsCompletedNo Results AvailableHypertriglyceridemia|HyperglycemiaOther: fat emulsions|Other: fat emulsionshttps://ClinicalTrials.gov/show/NCT00516997
156094156094Osteopathic Manipulative Treatment and Its Relationship to Autonomic Nervous System ActivityCompletedNo Results AvailableHealthyProcedure: Placebo|Procedure: Sham|Procedure: OMThttps://ClinicalTrials.gov/show/NCT00516984
156095156095The Use of Proton Pump Inhibitor for the Treatment of Non-erosive Gastro-oesophageal Reflux Disease in Chinese PopulationRecruitingNo Results AvailableGastroesophageal RefluxDrug: Esomeprazole 20mg once dailyhttps://ClinicalTrials.gov/show/NCT00516971
156096156096Pilot Study of the Safety and Clinical Efficacy of Topical Dermacynâ„¢ Wound Care to Treat Mild Diabetic Foot InfectionsCompletedNo Results AvailableFoot Ulcer, DiabeticDrug: Topical Dermacyn|Drug: Topical Dermacyn and Levofloxacin|Drug: Topical Saline and Levofloxacinhttps://ClinicalTrials.gov/show/NCT00516958
156097156097A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B CarriersCompletedNo Results AvailableHepatitis B|NeoplasmsDrug: Lamivudinehttps://ClinicalTrials.gov/show/NCT00516945
156098156098Pharmacogenomics of Antidepressant Response in Children and AdolescentsCompletedNo Results AvailableAnxiety Disorders|Depression|Eating Disorders|Obsessive-Compulsive Disorder|Suicide Preventionhttps://ClinicalTrials.gov/show/NCT00516932
156099156099Study of Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic PersonsCompletedHas ResultsObesity|Binge EatingDrug: Xenical + behavioral intervention|Behavioral: Behavioral intervention + placebohttps://ClinicalTrials.gov/show/NCT00516919
156100156100Clinical Performance of a Chlorhexidine Antimicrobial DressingCompletedHas ResultsCatheterizationDrug: Chlorhexidine gluconate|Drug: Transparent Adhesive Dressinghttps://ClinicalTrials.gov/show/NCT00516906
156101156101Natalizumab High Titer Immunogenicity and SafetyCompletedHas ResultsMultiple SclerosisBiological: BG00002-E (natalizumab high titer)https://ClinicalTrials.gov/show/NCT00516893
156102156102Targeting Peroxisome Proliferator-activated Receptor-gamma in Peritoneal Dialysis Patients - Will it Reduce Inflammation, Atherosclerosis, Calcification and Improve Survival of Peritoneal Dialysis Patients?RecruitingNo Results AvailableChronic Disease|Kidney Diseases|Cardiovascular DiseasesDrug: rosiglitazonehttps://ClinicalTrials.gov/show/NCT00516880
156103156103Does Sunbed Radiation With Mainly UVA Provoke Cutaneous Vitamin D Synthesis in Humans?CompletedNo Results AvailableHealthyRadiation: UV radiation|Radiation: UV radiationhttps://ClinicalTrials.gov/show/NCT00516867
156104156104A Study of the Use of Combination of Anti-cholinergic and Minor Tranquilliser in the Treatment of Non-cardiac Chest Pain - a Double Blind Placebo Controlled StudyRecruitingNo Results AvailableChest PainDrug: chlordiazepoxide 5 mg, clidinium 2.5 mg, twice dailyhttps://ClinicalTrials.gov/show/NCT00516854
156105156105A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal CancerTerminatedNo Results AvailableOvarian Cancer|Peritoneal NeoplasmsDrug: Volociximabhttps://ClinicalTrials.gov/show/NCT00516841
156106156106Sorafenib and Low Dose Cytarabine in Treating Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeCompletedNo Results AvailableLeukemia|Myelodysplastic SyndromesDrug: cytarabinehttps://ClinicalTrials.gov/show/NCT00516828
156107156107A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With DacarbazineCompletedNo Results AvailableMelanoma NeoplasmsDrug: KU-0059436 (AZD2281)(PARP inhibitor)|Drug: dacarbazinehttps://ClinicalTrials.gov/show/NCT00516802
156108156108The Innate Immune System and Inflammatory Bowel DiseaseActive, not recruitingNo Results AvailableUlcerative Colitis|Crohn's Diseasehttps://ClinicalTrials.gov/show/NCT00516776
156109156109Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and CisplatinTerminatedNo Results AvailableBladder CancerDrug: cisplatin|Drug: doxorubicin hydrochloride|Drug: methotrexate|Drug: vinblastine|Genetic: gene expression profiling|Procedure: neoadjuvant therapyhttps://ClinicalTrials.gov/show/NCT00516750
156110156110Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081)CompletedHas ResultsMigraineDrug: Comparator: rizatriptan benzoate|Drug: Comparator: Placebohttps://ClinicalTrials.gov/show/NCT00516737
156111156111Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or PaclitaxelActive, not recruitingNo Results AvailableTriple Negative Metastatic Breast Cancer|Advanced Ovarian Cancer|Carboplatin|PaclitaxelDrug: KU-0059436 (AZD2281)(PARP inhibitor)|Drug: Carboplatin|Drug: KU-0059436 (AZD2281)(PARP inhibitor)|Drug: Paclitaxel|Drug: KU-0059436 (AZD2281)(PARP inhibitor)|Drug: Paclitaxel + Carboplatinhttps://ClinicalTrials.gov/show/NCT00516724
156112156112Role of Volatile Anesthetics for Hepatic ProtectionCompletedNo Results AvailableReperfusion InjuryDrug: Sevofluranehttps://ClinicalTrials.gov/show/NCT00516711
156113156113Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast CancerCompletedNo Results AvailableBreast CancerGenetic: polymorphism analysis|Other: high performance liquid chromatography|Other: laboratory biomarker analysis|Procedure: radiomammographyhttps://ClinicalTrials.gov/show/NCT00516698
156114156114Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer (NSCLC) Stages IIIB/IVTerminatedNo Results AvailableNon-small-cell Lung Cancer (NSCLC) Stage IIIb/IVBiological: Recombinant Human rEGF-P64K/Montanide Vaccinehttps://ClinicalTrials.gov/show/NCT00516685
156115156115Phase I Study of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid Tumors.Active, not recruitingNo Results AvailableCarcinoma, Renal CellDrug: pazopanib|Drug: Lapatinibhttps://ClinicalTrials.gov/show/NCT00516672
156116156116ETEC Logistics Trial (TREK)CompletedNo Results AvailableDiarrheaBiological: Heat-Labile Enterotoxin of Escherichia coli (LT)|Biological: Placebohttps://ClinicalTrials.gov/show/NCT00516659
156117156117The BENEFICIAL Study: Evaluating the Efficacy and Safety of Alagebrium (ALT-711) in Patients With Chronic Heart FailureCompletedNo Results AvailableHeart FailureDrug: ALT-711|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00516646
156118156118Intervention Study to Improve Adherence in AsthmaCompletedNo Results AvailableAsthmaBehavioral: Extra information and supporthttps://ClinicalTrials.gov/show/NCT00516633
156119156119Fruits, Vegetables, and Whole Grains: A Community-based InterventionCompletedNo Results AvailableHeart Disease|Diabetes|HypertensionBehavioral: No further instruction|Behavioral: Food Delivery|Behavioral: Fruits (F), vegetables (V), and whole grain (WG) counseling|Behavioral: Counseling to reduce soft drink intake.|Behavioral: Food Delivery & F, V & WG counseling.|Behavioral: Food delivery & soft drink counseling|Behavioral: F, V, WG & soft drink counseling|Behavioral: Food delivery and F,V, WG & soft drink counselinghttps://ClinicalTrials.gov/show/NCT00516620
156120156120Enzastaurin and Temozolomide in Treating Patients With Primary GliomasActive, not recruitingNo Results AvailableBrain and Central Nervous System TumorsDrug: enzastaurin hydrochloride|Drug: temozolomide|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00516607

* Görseller ve İçerik tekif hakkına sahip olabilir